Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Senard

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Does fluoxetine aggravate Parkinson's disease? A pilot prospective studyJ L Montastruc, N Fabre, O Blin, et al.
British Journal of Clinical Pharmacology|July 1, 1993
Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in manP Barbe, J Galitzky, D Riviere, et al.
Therapie|September 1, 1992
[Antiparkinsonian drug consumption in a University Hospital Center 1981-1990]M Lapeyre-Mestre, B Chave, O Rascol, et al.
Clinical Neuropharmacology|June 1, 1996
Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's diseaseO Rascol, A J Lees, J M Senard, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 24, 1999
Increase in epinephrine-induced responsiveness during microgravity simulated by head-down bed rest in humansP Barbe, J Galitzky, C Thalamas, et al.
Neurology|September 1, 1988
Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trialO Rascol, J L Montastruc, J M Senard, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case reportJ M Senard, A Arias, M Berlan, et al.
Fundamental & Clinical Pharmacology|September 21, 2001
Changes in vascular alpha 1- and alpha 2-adrenoceptor responsiveness by selegiline treatmentM Pelat, P Verwaerde, M A Tran, et al.
Acta Anaesthesiologica Belgica|December 8, 2011
Lipomatous hypertrophy of the interatrial septum: the typical echographic aspect is worth being knownL Royer, G A Hans, J L Canivet, et al.
Clinical Neuropharmacology|February 27, 1999
L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteersN Andreu, J J Chalé, J M Senard, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
Does fluoxetine aggravate Parkinson's disease? A pilot prospective studyJ L Montastruc, N Fabre, O Blin, et al.
British Journal of Clinical Pharmacology|July 1, 1993
Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in manP Barbe, J Galitzky, D Riviere, et al.
Therapie|September 1, 1992
[Antiparkinsonian drug consumption in a University Hospital Center 1981-1990]M Lapeyre-Mestre, B Chave, O Rascol, et al.
Clinical Neuropharmacology|June 1, 1996
Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's diseaseO Rascol, A J Lees, J M Senard, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 24, 1999
Increase in epinephrine-induced responsiveness during microgravity simulated by head-down bed rest in humansP Barbe, J Galitzky, C Thalamas, et al.
Neurology|September 1, 1988
Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trialO Rascol, J L Montastruc, J M Senard, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case reportJ M Senard, A Arias, M Berlan, et al.
Fundamental & Clinical Pharmacology|September 21, 2001
Changes in vascular alpha 1- and alpha 2-adrenoceptor responsiveness by selegiline treatmentM Pelat, P Verwaerde, M A Tran, et al.
Acta Anaesthesiologica Belgica|December 8, 2011
Lipomatous hypertrophy of the interatrial septum: the typical echographic aspect is worth being knownL Royer, G A Hans, J L Canivet, et al.
Clinical Neuropharmacology|February 27, 1999
L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteersN Andreu, J J Chalé, J M Senard, et al.
Pageof 14